Low-density lipoprotein particle profiles compared with standard lipids measurements in the association with asymptomatic intracranial artery stenosis

Thien Vu,Yuichiro Yano,Huy Kien Tai Pham,Rajib Mondal,Mizuki Ohashi,Kaori Kitaoka,Mohammad Moniruzzaman,Sayuki Torii,Akihiko Shiino,Atsushi Tsuji,Takashi Hisamatsu,Tomonori Okamura,Keiko Kondo,Aya Kadota,Yoshiyuki Watanabe,Kazuhiko Nozaki,Hirotsugu Ueshima,Katsuyuki Miura
DOI: https://doi.org/10.1038/s41598-024-59523-4
IF: 4.6
2024-05-11
Scientific Reports
Abstract:The Shiga Epidemiological Study of Subclinical Atherosclerosis was conducted in Kusatsu City, Shiga, Japan, from 2006 to 2008. Participants were measured for LDL-p through nuclear magnetic resonance technology. 740 men participated in follow-up and underwent 1.5 T brain magnetic resonance angiography from 2012 to 2015. Participants were categorized as no-ICAS, and ICAS consisted of mild-ICAS (1 to < 50%) and severe-ICAS (≥ 50%) in any of the arteries examined. After exclusion criteria, 711 men left for analysis, we used multiple logistic regression to examine the association between lipid profiles and ICAS prevalence. Among the study participants, 205 individuals (28.8%) had ICAS, while 144 individuals (20.3%) demonstrated discordance between LDL-c and LDL-p levels. The discordance "low LDL-c–high LDL-p" group had the highest ICAS risk with an adjusted OR (95% CI) of 2.78 (1.55–5.00) in the reference of the concordance "low LDL-c–low LDL-p" group. This was followed by the concordance "high LDL-c–high LDL-p" group of 2.56 (1.69–3.85) and the discordance "high LDL-c–low LDL-p" group of 2.40 (1.29–4.46). These findings suggest that evaluating LDL-p levels alongside LDL-c may aid in identifying adults at a higher risk for ICAS.
multidisciplinary sciences
What problem does this paper attempt to address?
The problem this paper attempts to address is: evaluating the association between low-density lipoprotein particles (LDL-p) and intracranial artery stenosis (ICAS), and exploring its potential advantages over traditional low-density lipoprotein cholesterol (LDL-c) in predicting ICAS risk. Specifically, the researchers aim to address this issue through the following points: 1. **Evaluate the relationship between LDL-p and ICAS**: Measure LDL-p levels using nuclear magnetic resonance (NMR) technology and analyze their association with ICAS. 2. **Compare the predictive ability of LDL-p and LDL-c**: Assess the relative importance of LDL-p and LDL-c in predicting ICAS risk. 3. **Explore the inconsistency between LDL-c and LDL-p**: Analyze the risk of ICAS in individuals with inconsistent levels of LDL-c and LDL-p, particularly the "low LDL-c–high LDL-p" group. The research background indicates that although LDL-c is an important marker for cardiovascular diseases, the risk of ICAS still exists even when LDL-c levels are reduced. Therefore, exploring other lipid parameters, such as LDL-p, may help to more comprehensively understand this residual risk.